US sales of Humalog in Q3 were nearly $415 million, an increase of 10% compared with last year’s Q3, driven more by increased prices ... (insulin aspart injection) in September, and its long ...

and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir, a long-acting insulin, "failed to take into consideration patient access to affordable, long-acting insulin ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...